Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2018-09-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment
regimen of anifrolumab versus placebo in adult participants with moderately to severely
active, autoantibody-positive systemic lupus erythematosus (SLE).